Table of Contents

Overview

ETS1 is one of a number of genes affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. This gene has some recurrent sites of mutations (hot spots). The mutation pattern in DLBCL implies the preferential accumulation of inactivating mutations.

Relevance tier by entity

Cannot include /table1_ETS1.md - does not exist yet

Warnings

The variants reported in this gene in BL failed QC

Mutation incidence in large patient cohorts (GAMBL reanalysis)

Cannot include /DLBCL_ETS1.md - does not exist yet

Cannot include /FL_ETS1.md - does not exist yet

Mutation pattern and selective pressure estimates

Cannot include /dnds_ETS1.md - does not exist yet

aSHM regions

chr_name hg19_start hg19_end region regulatory_comment
chr11 128339774 128345731 intron enhancer
chr11 128388492 128394163 TSS-2 active_promoter

ETS1 Hotspots

Chromosome Coordinate (hg19) ref>alt HGVSp
chr11 128391889 T>A M1?
chr11 128391888 A>C M1?
chr11 128391871 G>A L7F
chr11 128391867 T>C K8R
chr11 128391865 GC>CT P9A
chr11 128391865 G>C P9A
chr11 128391865 G>A P9S
chr11 128391861 G>A T10I
chr11 128391859 G>C L11V
chr11 128391855 G>C T12S
chr11 128391855 G>A T12I
chr11 128391853 T>C I13V
chr11 128391853 T>A I13F
chr11 128391848 G>C I14M
chr11 128391846 T>C K15R
chr11 128391841 C>G E17Q
chr11 128391841 C>A E17*
chr11 128391824 C>G E22D
chr11 128391823 G>A L23F

Cannot include /browser_ETS1.md - does not exist yet

Expression

Representative Mutations

BL1

Rating ★ ☆ ☆ ☆ ☆

Rating ★ ☆ ☆ ☆ ☆

Cannot include /mermaid_ETS1.md - does not exist yet

References

1.
Panea R, Love C, Shingleton JR, Reddy A, Bailey J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N, Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S, Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome landscape of Burkitt lymphoma subtypes. Blood. 2019;
2.
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJM, Connors JM, Hirst M, Gascoyne RD, Marra MA. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011 Jul 27;476(7360):298–303. PMCID: PMC3210554

Citing

If you use the information or data from this site, please cite

Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.